Ladenburg Thalmann Financial Services’s Fresh Tracks Therapeutics, Inc. Common Stock FRTX Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio FRTX Stock Details FRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Hold	0	–	–	–	4997
2016 Q4	–	Hold	0	–	–	–	4977
2016 Q3	–	Hold	0	–	–	–	4900
2015 Q4	–	Hold	0	–	–	–	4815
2015 Q3	–	Hold	0	–	–	–	4767
2015 Q2	–	Sell	-1	Closed	-$3.14K	–	4555
2015 Q1	$2K	Hold	1	–	–	﹤0.01%	4317
2014 Q4	$2K	Hold	1	–	–	﹤0.01%	4090
2014 Q3	$2K	Hold	1	–	–	﹤0.01%	3705
2014 Q2	$2K	Hold	1	–	–	﹤0.01%	3671
2014 Q1	$3K	Hold	1	–	–	﹤0.01%	3442
2013 Q4	$5K	Sell	1 -1	-50%	-$3.79K	﹤0.01%	3272
2013 Q3	$6K	Hold	2	–	–	﹤0.01%	3110
2013 Q2	$16K	Buy	+2	New	+$22.2K	﹤0.01%	2467

Other funds holding FRTX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 19.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Ladenburg Thalmann Financial Services's FRTX Position: Q1 2017 in Review

Ladenburg Thalmann Financial Services held its Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) position steady in Q1 2017 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #4997.

Ladenburg Thalmann Financial Services first reported a position in FRTX in Q2 2013 and has held it in 8 quarters since. The position peaked at $16K in Q2 2013. 27 funds tracked by Wall St. Rank hold FRTX as of Q1 2017.

Ladenburg Thalmann Financial Services held 0 shares of Fresh Tracks Therapeutics, Inc. Common Stock worth $0 as of Q1 2017.
Ladenburg Thalmann Financial Services left its Fresh Tracks Therapeutics, Inc. Common Stock share count unchanged in Q1 2017.
Fresh Tracks Therapeutics, Inc. Common Stock made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q1 2017, its #4997 holding.
Ladenburg Thalmann Financial Services first reported a position in Fresh Tracks Therapeutics, Inc. Common Stock in Q2 2013 and has held it in 8 quarters since.
Ladenburg Thalmann Financial Services's Fresh Tracks Therapeutics, Inc. Common Stock position peaked at $16K in Q2 2013.
27 funds tracked by Wall St. Rank held Fresh Tracks Therapeutics, Inc. Common Stock as of Q1 2017.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q1 2017, filed 15 May 2017.